debrisoquin and cyclohexanol

debrisoquin has been researched along with cyclohexanol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dorne, JL; Renwick, AG; Slob, W; Walton, K	1
AL-Shurbaji, A; Annas, A; Dahl, ML; Lindh, JD; Meurling, L	1

Trials

1 trial(s) available for debrisoquin and cyclohexanol

Article	Year
Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine. European journal of clinical pharmacology, 2003, Volume: 59, Issue:5-6 Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Debrisoquin; Drug Interactions; Female; Genotype; Half-Life; Humans; Ketoconazole; Male; Middle Aged; Phenotype; Venlafaxine Hydrochloride; White People	2003

Article

Year

Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.

European journal of clinical pharmacology, 2003, Volume: 59, Issue:5-6

Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Debrisoquin; Drug Interactions; Female; Genotype; Half-Life; Humans; Ketoconazole; Male; Middle Aged; Phenotype; Venlafaxine Hydrochloride; White People

2003

Other Studies

1 other study(ies) available for debrisoquin and cyclohexanol

Article	Year
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2002, Volume: 40, Issue:11 Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride	2002

Article

Year

Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2002, Volume: 40, Issue:11

Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride

2002